Overseas weight loss drug leader Novo Nordisk is expected to increase its annual operating profit by 40% to 46% at a constant exchange rate.

On October 13th of this year, the stock price of American pharmaceutical giant Lilly reached a historic high of $629.97 per share. After three consecutive years of significant gains, Lilly became the ...

According to a recent report by data analysis company GlobalData, the newly approved weight loss drug Zepbound by American pharmaceutical company Eli Lilly will have sales of $4.1 billion in the Unit ...

On November 30th local time, Novo Nordisk USA announced that as part of its ongoing commitment to patient safety, the company is taking several additional legal actions to protect American patients a ...

The best performing companies in the healthcare sector this year have all benefited from the weight loss drug boom. Pfizer also hopes to make a comeback with an oral weight loss drug, but the latest ...

On Monday Eastern Time, Swiss pharmaceutical giant Roche announced its entry into the weight loss drug market through acquisition, challenging weight loss drug giants Novo Nordisk and Lilly. After th ...

According to the Red Star Capital Bureau, the stock price of weight loss drug giant LY. US fell at the beginning of trading on December 11th local time, with a drop of over 5% during the trading sess ...

An overseas star fund manager who outperformed 97% of his peers in performance this year shared his vision of next year's "investment experience" this week. One of the biggest highlights in his outlo ...

According to a source, Novo Nordisk's legal team in India is collaborating with India's online e-commerce platform IndiaMART to develop a framework to remove counterfeit weight loss drugs from the pl ...

Apple's sudden bearish news. On December 18th local time, Apple announced that starting from 3pm local time on December 21st, the official website of Apple in the United States will stop selling the ...

Throughout this year, major international pharmaceutical companies have made breakthroughs in multiple fields, which have not only benefited humanity but also changed the industry's landscape in the ...

The latest discovery by US regulatory agencies that GLP-1 weight loss drugs such as Wegovy under Novo Nordisk are not associated with suicidal thoughts is a positive signal for these popular drugs an ...

Entering 2024, the track of weight loss pills remains hot. On January 23rd local time, Danish pharmaceutical giant Novo Nordisk and Swiss biotechnology company EraCal Therapeutics (hereinafter referr ...

Novo Nordisk announced a $11 billion acquisition of three production factories to meet the growing demand for weight loss drugs. On January 31st, Novo Nordisk released its 2023 results, with a total ...

Global weight loss drug leader Novo Nordisk has made new moves in expanding production. On February 5th, Novo Nordisk announced that its controlling shareholder Novo Holdings had agreed to acquire CD ...

On Wednesday (February 14) Eastern Time, well-known hedge fund Bridgewater submitted its US stock holdings report (13F) as of the end of the fourth quarter of last year to the Securities and Exchange ...

JPMorgan said in its latest report on Wednesday that retail investors sold most of the stocks in the "tech seven" last week, with the focus shifting to pharmaceutical companies such as Eli Lilly. Acc ...

The GLP-1 weight loss drug, which is in a race for development, is also highly competitive in terms of production capacity. Recently, Lilly held a groundbreaking ceremony for a new factory in Frankfu ...

On Thursday, weight loss drug giant Novo Nordisk held a earnings conference call, promising to further adopt a price reduction strategy in the US market. The company's Chief Financial Officer, Karste ...

American pharmaceutical company Anjin Weight Loss Medicine has attracted attention, with Novo Nordisk's stock price falling 5%.